Showing results (81-90 of 3,223) with videos related to

Sort By:
Pageof 323
Breast Cancer (Dove Medical Press)|March 21, 2014
Tamoxifen for women at high risk of breast cancerSafia A Nazarali, Steven A Narod
Journal of the National Cancer Institute|October 17, 2002
Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomyKelly A Metcalfe, Steven A Narod
BJC Reports|November 8, 2024
Commentary: Why is genetic testing underutilized worldwide? The case for hereditary breast cancerHolly J Pederson, Steven A Narod
Gynecologic Oncology|April 15, 2008
Ovarian cancer risk is associated with a common variant in the promoter sequence of the mismatch repair gene MLH1Ian Harley, Barry Rosen, Harvey A Risch, et al.
Familial Cancer|September 3, 2010
BRCA1 and BRCA2 families and the risk of skin cancerOphira M Ginsburg, Charmaine Kim-Sing, William D Foulkes, et al.
Gynecologic Oncology|July 16, 2014
The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancerBarry Rosen, Stephane Laframboise, Sarah Ferguson, et al.
Breast Cancer Research and Treatment|February 4, 2009
Patterns of recurrence in the basal and non-basal subtypes of triple-negative breast cancersSharon Nofech-Mozes, Maureen Trudeau, Harriet K Kahn, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|December 2, 2017
BRCA Mutation Status Is Not Associated With Increased Hematologic Toxicity Among Patients Undergoing Platinum-Based Chemotherapy for Ovarian CancerJoanne Kotsopoulos, Karla Willows, Sandra Trat, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 28, 2014
Telomere length and mortality following a diagnosis of ovarian cancerJoanne Kotsopoulos, Jennifer Prescott, Immaculata De Vivo, et al.
Breast Cancer Research and Treatment|January 7, 2019
Age-specific risks of incident, contralateral and ipsilateral breast cancer among 1776 Polish BRCA1 mutation carriersJan Lubinski, Tomasz Huzarski, Jacek Gronwald, et al.
Pageof 323